| abstract |
The present invention relates to the field of anti-inflammatory substances, and more particularly to novel compounds that act as antagonists of mammalian adhesion proteins known as selectins. In some embodiments, a method of treating a selectin mediated disease comprising administering a compound of Formula (I) is provided.n n n Formula In n n n n n n n In Formula I above,n n n Configuration variables are as defined herein. |